This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
News: Publications

Commentary on HDL markers in cardiovascular risk prediction: ethnicity matters

Tuesday 14 July 2020   (0 Comments)
Share |

High-density lipoprotein (HDL) has had a chequered history. Epidemiologic evidence supports HDL cholesterol (HDL-C) as a marker for cardiovascular risk, providing the rationale for its incorporation in SCORE, a cardiovascular risk algorithm. Investigation of the potential of HDL-targeted therapies to reduce cardiovascular events in high-risk patients has, however, proved disappointing in clinical trials.

To the commentary by Jane K. Stock >>


Membership Software Powered by YourMembership  ::  Legal